Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: Implications for reparative therapy in Parkinson's disease

Lidia Cova, Patrizia Bossolasco, Marie Therese Armentero, Valentina Diana, Eleonora Zennaro, Manuela Mellone, Cinzia Calzarossa, Silvia Cerri, Giorgio Lambertenghi Deliliers, Elio Polli, Fabio Blandini, Vincenzo Silani

Research output: Contribution to journalArticle

Abstract

Stem cell (SC) transplantation represents a promising tool to treat neurodegenerative disorders, such as Parkinson's disease (PD), but positive therapeutic outcomes require elucidation of the biological mechanisms involved. Therefore, we investigated human Mesenchymal SCs (hMSCs) ability to protect murine differentiated Neural SCs (mdNSCs) against the cytotoxic effects of 6-hydroxydopamine (6-OHDA) in a co-culture model mimicking the in vivo neurovascular niche. The internalization of 6-OHDA mainly relies on its uptake by the dopamine active transporter (DAT), but its toxicity could also involve other pathways. We demonstrated that mdNSCs consistently expressed DAT along the differentiative process. Exposure to 6-OHDA did not affect hMSCs, but induced DAT-independent apoptosis in mdNSCs with generation of reactive oxygen species and caspases 3/7 activation. The potential neuroprotective action of hMSCs on mdNSCs exposed to 6-OHDA was tested in different co-culture conditions, in which hMSCs were added to mdNSCs prior to, simultaneously, or after 6-OHDA treatment. In the presence of the neurotoxin, the majority of mdNSCs acquired an apoptotic phenotype, while co-cultures with hMSCs significantly increased their survival (up to 70%) in all conditions. Multiplex human angiogenic array analysis on the conditioned media demonstrated that cytokine release by hMSCs was finely modulated. Moreover, sole growth factor addition yielded a similar neuroprotective effect on mdNSCs. In conclusion, our findings demonstrate that hMSCs protect mdNSCs against 6-OHDA neurotoxicity, and rescue cells from ongoing neurodegeneration likely through the release of multiple cytokines. Our findings provide novel insights for the development of therapeutic strategies designed to counteract the neurodegenerative processes of PD.

Original languageEnglish
Pages (from-to)289-304
Number of pages16
JournalApoptosis
Volume17
Issue number3
DOIs
Publication statusPublished - Mar 2012

Fingerprint

Oxidopamine
Neuroprotective Agents
Stem cells
Mesenchymal Stromal Cells
Cell culture
Parkinson Disease
Dopamine Plasma Membrane Transport Proteins
Coculture Techniques
Dopamine
Therapeutics
Cytokines
Caspase 7
Neurotoxins
Conditioned Culture Medium
Caspase 3
Stem Cell Transplantation
Toxicity
Reactive Oxygen Species
Intercellular Signaling Peptides and Proteins
Neurodegenerative Diseases

Keywords

  • Cell therapy
  • Cytokines
  • Dopamine transporter
  • Neural stem cells
  • Neurorescue

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry
  • Biochemistry, medical
  • Cancer Research
  • Pharmaceutical Science
  • Pharmacology
  • Medicine(all)

Cite this

Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine : Implications for reparative therapy in Parkinson's disease. / Cova, Lidia; Bossolasco, Patrizia; Armentero, Marie Therese; Diana, Valentina; Zennaro, Eleonora; Mellone, Manuela; Calzarossa, Cinzia; Cerri, Silvia; Lambertenghi Deliliers, Giorgio; Polli, Elio; Blandini, Fabio; Silani, Vincenzo.

In: Apoptosis, Vol. 17, No. 3, 03.2012, p. 289-304.

Research output: Contribution to journalArticle

Cova, Lidia ; Bossolasco, Patrizia ; Armentero, Marie Therese ; Diana, Valentina ; Zennaro, Eleonora ; Mellone, Manuela ; Calzarossa, Cinzia ; Cerri, Silvia ; Lambertenghi Deliliers, Giorgio ; Polli, Elio ; Blandini, Fabio ; Silani, Vincenzo. / Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine : Implications for reparative therapy in Parkinson's disease. In: Apoptosis. 2012 ; Vol. 17, No. 3. pp. 289-304.
@article{4baea85e09504f069e3babf06a091e9a,
title = "Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: Implications for reparative therapy in Parkinson's disease",
abstract = "Stem cell (SC) transplantation represents a promising tool to treat neurodegenerative disorders, such as Parkinson's disease (PD), but positive therapeutic outcomes require elucidation of the biological mechanisms involved. Therefore, we investigated human Mesenchymal SCs (hMSCs) ability to protect murine differentiated Neural SCs (mdNSCs) against the cytotoxic effects of 6-hydroxydopamine (6-OHDA) in a co-culture model mimicking the in vivo neurovascular niche. The internalization of 6-OHDA mainly relies on its uptake by the dopamine active transporter (DAT), but its toxicity could also involve other pathways. We demonstrated that mdNSCs consistently expressed DAT along the differentiative process. Exposure to 6-OHDA did not affect hMSCs, but induced DAT-independent apoptosis in mdNSCs with generation of reactive oxygen species and caspases 3/7 activation. The potential neuroprotective action of hMSCs on mdNSCs exposed to 6-OHDA was tested in different co-culture conditions, in which hMSCs were added to mdNSCs prior to, simultaneously, or after 6-OHDA treatment. In the presence of the neurotoxin, the majority of mdNSCs acquired an apoptotic phenotype, while co-cultures with hMSCs significantly increased their survival (up to 70{\%}) in all conditions. Multiplex human angiogenic array analysis on the conditioned media demonstrated that cytokine release by hMSCs was finely modulated. Moreover, sole growth factor addition yielded a similar neuroprotective effect on mdNSCs. In conclusion, our findings demonstrate that hMSCs protect mdNSCs against 6-OHDA neurotoxicity, and rescue cells from ongoing neurodegeneration likely through the release of multiple cytokines. Our findings provide novel insights for the development of therapeutic strategies designed to counteract the neurodegenerative processes of PD.",
keywords = "Cell therapy, Cytokines, Dopamine transporter, Neural stem cells, Neurorescue",
author = "Lidia Cova and Patrizia Bossolasco and Armentero, {Marie Therese} and Valentina Diana and Eleonora Zennaro and Manuela Mellone and Cinzia Calzarossa and Silvia Cerri and {Lambertenghi Deliliers}, Giorgio and Elio Polli and Fabio Blandini and Vincenzo Silani",
year = "2012",
month = "3",
doi = "10.1007/s10495-011-0679-9",
language = "English",
volume = "17",
pages = "289--304",
journal = "Apoptosis : an international journal on programmed cell death",
issn = "1360-8185",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine

T2 - Implications for reparative therapy in Parkinson's disease

AU - Cova, Lidia

AU - Bossolasco, Patrizia

AU - Armentero, Marie Therese

AU - Diana, Valentina

AU - Zennaro, Eleonora

AU - Mellone, Manuela

AU - Calzarossa, Cinzia

AU - Cerri, Silvia

AU - Lambertenghi Deliliers, Giorgio

AU - Polli, Elio

AU - Blandini, Fabio

AU - Silani, Vincenzo

PY - 2012/3

Y1 - 2012/3

N2 - Stem cell (SC) transplantation represents a promising tool to treat neurodegenerative disorders, such as Parkinson's disease (PD), but positive therapeutic outcomes require elucidation of the biological mechanisms involved. Therefore, we investigated human Mesenchymal SCs (hMSCs) ability to protect murine differentiated Neural SCs (mdNSCs) against the cytotoxic effects of 6-hydroxydopamine (6-OHDA) in a co-culture model mimicking the in vivo neurovascular niche. The internalization of 6-OHDA mainly relies on its uptake by the dopamine active transporter (DAT), but its toxicity could also involve other pathways. We demonstrated that mdNSCs consistently expressed DAT along the differentiative process. Exposure to 6-OHDA did not affect hMSCs, but induced DAT-independent apoptosis in mdNSCs with generation of reactive oxygen species and caspases 3/7 activation. The potential neuroprotective action of hMSCs on mdNSCs exposed to 6-OHDA was tested in different co-culture conditions, in which hMSCs were added to mdNSCs prior to, simultaneously, or after 6-OHDA treatment. In the presence of the neurotoxin, the majority of mdNSCs acquired an apoptotic phenotype, while co-cultures with hMSCs significantly increased their survival (up to 70%) in all conditions. Multiplex human angiogenic array analysis on the conditioned media demonstrated that cytokine release by hMSCs was finely modulated. Moreover, sole growth factor addition yielded a similar neuroprotective effect on mdNSCs. In conclusion, our findings demonstrate that hMSCs protect mdNSCs against 6-OHDA neurotoxicity, and rescue cells from ongoing neurodegeneration likely through the release of multiple cytokines. Our findings provide novel insights for the development of therapeutic strategies designed to counteract the neurodegenerative processes of PD.

AB - Stem cell (SC) transplantation represents a promising tool to treat neurodegenerative disorders, such as Parkinson's disease (PD), but positive therapeutic outcomes require elucidation of the biological mechanisms involved. Therefore, we investigated human Mesenchymal SCs (hMSCs) ability to protect murine differentiated Neural SCs (mdNSCs) against the cytotoxic effects of 6-hydroxydopamine (6-OHDA) in a co-culture model mimicking the in vivo neurovascular niche. The internalization of 6-OHDA mainly relies on its uptake by the dopamine active transporter (DAT), but its toxicity could also involve other pathways. We demonstrated that mdNSCs consistently expressed DAT along the differentiative process. Exposure to 6-OHDA did not affect hMSCs, but induced DAT-independent apoptosis in mdNSCs with generation of reactive oxygen species and caspases 3/7 activation. The potential neuroprotective action of hMSCs on mdNSCs exposed to 6-OHDA was tested in different co-culture conditions, in which hMSCs were added to mdNSCs prior to, simultaneously, or after 6-OHDA treatment. In the presence of the neurotoxin, the majority of mdNSCs acquired an apoptotic phenotype, while co-cultures with hMSCs significantly increased their survival (up to 70%) in all conditions. Multiplex human angiogenic array analysis on the conditioned media demonstrated that cytokine release by hMSCs was finely modulated. Moreover, sole growth factor addition yielded a similar neuroprotective effect on mdNSCs. In conclusion, our findings demonstrate that hMSCs protect mdNSCs against 6-OHDA neurotoxicity, and rescue cells from ongoing neurodegeneration likely through the release of multiple cytokines. Our findings provide novel insights for the development of therapeutic strategies designed to counteract the neurodegenerative processes of PD.

KW - Cell therapy

KW - Cytokines

KW - Dopamine transporter

KW - Neural stem cells

KW - Neurorescue

UR - http://www.scopus.com/inward/record.url?scp=84862272787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862272787&partnerID=8YFLogxK

U2 - 10.1007/s10495-011-0679-9

DO - 10.1007/s10495-011-0679-9

M3 - Article

C2 - 22160861

AN - SCOPUS:84862272787

VL - 17

SP - 289

EP - 304

JO - Apoptosis : an international journal on programmed cell death

JF - Apoptosis : an international journal on programmed cell death

SN - 1360-8185

IS - 3

ER -